Hill Publishing Group | contact@hillpublisher.com

Hill Publishing Group

Location:Home / Journals / International Journal of Clinical and Experimental Medicine Research /

DOI:http://dx.doi.org/10.26855/ijcemr.2021.07.005

Oxygen Deficiency at a COVID-19 Epicenter: A Buying-Time Solution

Date: May 21,2021 |Hits: 178 Download PDF How to cite this paper

Ailan Chen1,3, Qingquan Lv2, Zhifang Cai3, Yingjie Song3, Jianheng Zhang3,4, Jiaxing Xie3,4,*

1Department of Cardiology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

2Medical Department, Hankou Hospital of Wuhan City, Wuhan, China.

3Department of Pulmonary and Critical Care Medicine, Hankou Hospital of Wuhan City, Wuhan, China.

4Department of Pulmonary and Critical Care Medicine, National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

*Corresponding author: Jiaxing Xie

Abstract

Medical oxygen is a vital part of treatment for the coronavirus. But huge numbers of COVID-19 patients in a city may crush the entire medical care system and debilitate the medical supply chain by using up the medical resources, such as oxygen. Sustainable oxygen supply has been an issue in industrialized and is still biting poorer countries battling COVID-19. We analysis the reasons of shortages of oxygen in the pandemic and present our experiences in Wuhan in order to provide an emergent handling protocol to cities under similar circumstances during the ongoing pandemic. Strategies for improving oxygen supply, expanding the use of oxygen concentrators, and algorithmizing oxygen therapy, may buy more time for both medical care providers and COVID-19 patients. Investment in oxygen infrastructure should be prioritized not only for COVID-19 but also for other unpredictable pandemic and conditions that cause hypoxaemia.

References

[1] Wu, Z., McGoogan, J. M. (2020). Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA, 323: 1239-1242.

[2] Bi. Q., Wu. Y., Mei. S., Ye. C., Zou. X., Zhang. Z., Liu. X., Wei. L., Truelove. S. A., Zhang, T., et al. (2020). Epidemiology and transmission of COVID-19 in 391 cases and 1,286 of their close contacts in Shenzhen, China: a retrospective cohort study. Lancet Infect Dis, 20: 911-919.

[3] Guan, W. J., Ni, Z. Y., Hu, Y., Liang, W. H., Ou, C. Q., He, J. X., Liu, L., Shan, H., Lei, C. L., Hui, D. S. C., et al. (2020). Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med., 382: 1708-1720.

[4] World Health Organization. (2020). Oxygen sources and distribution for COVID-19 treatment centres.

[5] Stein, F., Perry, M., Banda, G., Woolhouse, M., Mutapi, F. (2020). Oxygen provision to fight COVID-19 in sub-Saharan Africa. BMJ Glob Health, 5.

[6] World Health Organization. (2021). COVID-19 oxygen emergency impacting more than half a million people in low- and middle-income countries every day, as demand surges.

[7] The Guardian. (2020). Coronavirus: London hospital almost runs out of oxygen for Covid-19 patients.

[8] FORTUNE. (2020). Coronavirus treatment: Hospitals face supply shortage for COVID-19 patients.

[9] Eric, T. (2021). Potential Solutions to the COVID-19 Oxygen Crisis in the United States.

[10] Ritz, R. H., Previtera, J. E. (2008). Oxygen supplies during a mass casualty situation. Respir Care, 53: 215-224; discussion 224-215.

[11] Bolton, C. E., Annandale, J. A., Ebden, P. (2006). Comparison of an oxygen concentrator and wall oxygen in the assessment of patients undergoing long term oxygen therapy assessment. Chron Respir Dis., 3: 49-51.

[12] Siemieniuk, R. A. C., Chu, D. K., Kim, L. H., Güell-Rous, M. R., Alhazzani, W., Soccal, P. M., Karanicolas, P. J., Farhoumand, P. D., Siemieniuk, J. L. K., Satia, I., et al. (2018). Oxygen therapy for acutely ill medical patients: a clinical practice guideline. BMJ, 363:k4169.

[13] Chu, D. K., Kim, L. H., Young, P. J., Zamiri, N., Almenawer, S. A., Jaeschke, R., Szczeklik, W., Schünemann, H. J., Neary, J. D., Alhazzani, W. (2018). Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis. Lancet, 391: 1693-1705.

How to cite this paper

Oxygen Deficiency at a COVID-19 Epicenter: A Buying-Time Solution

How to cite this paper: Ailan Chen, Qingquan Lv, Zhifang Cai, Yingjie Song, Jianheng Zhang, Jiaxing Xie. (2021) Oxygen Deficiency at a COVID-19 Epicenter: A Buying-Time SolutionInternational Journal of Clinical and Experimental Medicine Research5(3), 260-263.

DOI: http://dx.doi.org/10.26855/ijcemr.2021.07.005

Volumes & Issues

Free HPG Newsletters

Add your e-mail address to receive free newsletters from Hill Publishing Group.

Contact us

Hill Publishing Group

8825 53rd Ave

Elmhurst, NY 11373, USA

E-mail: contact@hillpublisher.com

Copyright © 2019 Hill Publishing Group Inc. All Rights Reserved.